Wafik S. El-Deiry, MD, PhD, FACP· @weldeiry · X·· 2026-04-21评分60
正文 · 原文
I stopped by the poster presentation by Dr.
@ksmeza
on “Nuvisertib (TP-3654) and Dordaviprone (ONC201) synergize to reduce renal cell carcinoma cell viablity” presented at #AACR26 in San Diego. I spoke with her about her research at
@BrownUniversity
leading to a novel therapeutic
热度 11 · 11 赞 · 0 回复 · 0 转发
会议摘要
3174按 代号 TP-3654 对上
Nuvisertib (TP-3654) and Dordaviprone (ONC201) synergize to reduce renal cell carcinoma cell viabilityKimberly S. Meza, Sheldon L. Holder, Wafik S. Deiry
读摘要原文 →2937按 代号 ONC201 对上
Imipridones ONC201, ONC206, and ONC212 show potent killing and colony arrest of small-cell lung cancer cell lines.Audrey Y. Su, Connor Purcell, Shengliang Zhang, Lanlan Zhou, Ashley S. Uruchurtu, Wafik S. El-Deiry
读摘要原文 →948按 代号 ONC201 对上
TRAIL inducing drug, ONC201 prevents adenocarcinoma in transgenic KRASG12V mouse lung cancer modelKarthikkumar Venkatachalam, Gopal Pathuri, Nicole Stratton, Anil Singh, Nandini Kumar, Shizuko Sei, Vignesh Gunasekharan, Chinthalapally V. Rao, Venkateshwar Madka
读摘要原文 →来源：Wafik S. El-Deiry, MD, PhD, FACP · x.com